Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-GI: Switch from oral dopamine agonists to rotigotine transdermal patch in Parkinson's disease with gastrointestinal symptoms
2009-014341-84Phase 4Active
- Sponsor
- Schwarz Pharma
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rotigotine in Parkinson's disease (PD), sponsored by Schwarz Pharma. Primary endpoint: Efficacy variables after switch to rotigotine. Started Oct 2009; status: active.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-014341-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014341-84.